دورية أكاديمية
أعرض في EDS

Advances in the mechanism of small nucleolar RNA and its role in DNA damage response.

التفاصيل البيبلوغرافية
العنوان: Advances in the mechanism of small nucleolar RNA and its role in DNA damage response.
المؤلفون: Shen LP; Department of Radiobiology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, China., Zhang WC; Department of Radiobiology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, China., Deng JR; Graduate Collaborative Training Base of Academy of Military Sciences, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China., Qi ZH; Department of Radiobiology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, China., Lin ZW; Department of Radiobiology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, China., Wang ZD; Department of Radiobiology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, China. wangzhidong@bmi.ac.cn.; Graduate Collaborative Training Base of Academy of Military Sciences, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. wangzhidong@bmi.ac.cn.
المصدر: Military Medical Research [Mil Med Res] 2024 Aug 08; Vol. 11 (1), pp. 53. Date of Electronic Publication: 2024 Aug 08.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101643181 Publication Model: Electronic Cited Medium: Internet ISSN: 2054-9369 (Electronic) Linking ISSN: 20549369 NLM ISO Abbreviation: Mil Med Res Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [London] : BioMed Central, [2014]-
مواضيع طبية MeSH: RNA, Small Nucleolar*/genetics , DNA Damage*/physiology, Humans ; Genomic Instability
مستخلص: Small nucleolar RNAs (snoRNAs) were previously regarded as a class of functionally conserved housekeeping genes, primarily involved in the regulation of ribosome biogenesis by ribosomal RNA (rRNA) modification. However, some of them are involved in several biological processes via complex molecular mechanisms. DNA damage response (DDR) is a conserved mechanism for maintaining genomic stability to prevent the occurrence of various human diseases. It has recently been revealed that snoRNAs are involved in DDR at multiple levels, indicating their relevant theoretical and clinical significance in this field. The present review systematically addresses four main points, including the biosynthesis and classification of snoRNAs, the mechanisms through which snoRNAs regulate target molecules, snoRNAs in the process of DDR, and the significance of snoRNA in disease diagnosis and treatment. It focuses on the potential functions of snoRNAs in DDR to help in the discovery of the roles of snoRNAs in maintaining genome stability and pathological processes.
(© 2024. The Author(s).)
References: RNA. 2003 Nov;9(11):1362-70. (PMID: 14561886)
Nat Genet. 2016 Jan;48(1):53-8. (PMID: 26595770)
Annu Rev Biochem. 2010;79:181-211. (PMID: 20192759)
Cell Res. 2008 Jan;18(1):134-47. (PMID: 18157161)
Nucleic Acids Res. 2020 Feb 28;48(4):1627-1651. (PMID: 31828325)
Mol Cell. 2020 Sep 17;79(6):934-949.e14. (PMID: 32822587)
Nucleic Acids Res. 2018 Jan 4;46(D1):D371-D374. (PMID: 29106639)
Cell Metab. 2015 Jun 2;21(6):855-67. (PMID: 25980348)
Leukemia. 2012 Sep;26(9):2052-60. (PMID: 22522792)
Nucleic Acids Res. 2022 Jun 24;50(11):6284-6299. (PMID: 35648437)
Nat Genet. 2008 Dec;40(12):1413-5. (PMID: 18978789)
Cell Metab. 2011 Jul 6;14(1):33-44. (PMID: 21723502)
Nucleic Acids Res. 2020 Sep 4;48(15):8686-8703. (PMID: 32710630)
Sci Rep. 2020 Jun 30;10(1):10641. (PMID: 32606371)
RNA Biol. 2022 Jan;19(1):412-418. (PMID: 35389826)
Mol Cell. 2021 Jan 21;81(2):355-369.e10. (PMID: 33321093)
Cell Discov. 2022 Nov 1;8(1):117. (PMID: 36316318)
Cell. 2014 Sep 25;159(1):148-162. (PMID: 25219674)
Mol Cell Biol. 2011 Jan;31(2):365-74. (PMID: 21041475)
Proc Natl Acad Sci U S A. 2015 Oct 20;112(42):E5699-705. (PMID: 26371324)
J Exp Clin Cancer Res. 2015 May 15;34:49. (PMID: 25975345)
Nat Rev Mol Cell Biol. 2008 Aug;9(8):616-27. (PMID: 18594563)
Proc Natl Acad Sci U S A. 2002 May 28;99(11):7536-41. (PMID: 12032318)
Cancer Commun (Lond). 2021 Feb;41(2):140-153. (PMID: 33455092)
Annu Rev Genet. 2021 Nov 23;55:285-307. (PMID: 34813349)
Nat Neurosci. 2019 Sep;22(9):1521-1532. (PMID: 31455884)
Science. 2007 May 25;316(5828):1160-6. (PMID: 17525332)
Mol Cell. 2010 Oct 22;40(2):216-27. (PMID: 20965417)
PLoS Genet. 2013;9(8):e1003702. (PMID: 23950734)
PLoS Comput Biol. 2009 Sep;5(9):e1000507. (PMID: 19763159)
Mol Cell. 2017 Jun 15;66(6):801-817. (PMID: 28622525)
Trends Genet. 2019 Feb;35(2):104-117. (PMID: 30563726)
Biochimie. 2019 Sep;164:17-21. (PMID: 31078583)
Oncotarget. 2015 Jul 10;6(19):17430-44. (PMID: 26041889)
Mol Cell. 2021 Jul 1;81(13):2808-2822.e10. (PMID: 34111399)
Antioxidants (Basel). 2021 Mar 06;10(3):. (PMID: 33800761)
Nat Rev Clin Oncol. 2020 Jul;17(7):395-417. (PMID: 32203277)
Nature. 2007 Jun 7;447(7145):730-4. (PMID: 17554310)
EMBO J. 2000 Nov 15;19(22):6218-29. (PMID: 11080167)
Sci Rep. 2018 Mar 23;8(1):5101. (PMID: 29572515)
Elife. 2019 Sep 03;8:. (PMID: 31478838)
Yale J Biol Med. 2019 Dec 20;92(4):771-779. (PMID: 31866794)
NAR Cancer. 2021 Jul 09;3(3):zcab026. (PMID: 34316713)
Sci Rep. 2015 Feb 26;5:8588. (PMID: 25715874)
Cell Biol Toxicol. 2023 Aug;39(4):1377-1394. (PMID: 36087186)
EMBO J. 1999 Jan 15;18(2):457-69. (PMID: 9889201)
Nat Cell Biol. 2011 Feb;13(2):132-41. (PMID: 21258367)
Cell Death Discov. 2021 Nov 10;7(1):347. (PMID: 34759267)
Nature. 2004 Nov 18;432(7015):316-23. (PMID: 15549093)
Cell Death Discov. 2023 Jun 27;9(1):192. (PMID: 37369687)
Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11485-9. (PMID: 8524788)
Minerva Med. 2017 Oct;108(5):396-404. (PMID: 28466632)
Genes Dev. 2015 Jun 1;29(11):1151-63. (PMID: 26019174)
Annu Rev Biochem. 2017 Jun 20;86:715-748. (PMID: 28441057)
Mol Oncol. 2022 May;16(9):1947-1965. (PMID: 35100495)
Clin Cancer Res. 2002 Nov;8(11):3527-38. (PMID: 12429644)
Cell Biol Int. 2021 May;45(5):1091-1097. (PMID: 33501699)
J Clin Oncol. 2022 Jan 1;40(1):32-39. (PMID: 34597127)
DNA Repair (Amst). 2021 Feb;98:103036. (PMID: 33429260)
J Exp Med. 2018 May 7;215(5):1287-1299. (PMID: 29622565)
Front Oncol. 2021 Mar 19;11:620213. (PMID: 33816250)
Nat Rev Clin Oncol. 2020 Aug;17(8):457-474. (PMID: 32303702)
Proc Natl Acad Sci U S A. 2016 Mar 22;113(12):E1625-34. (PMID: 26957605)
Wiley Interdiscip Rev RNA. 2015 Jul-Aug;6(4):381-97. (PMID: 25879954)
Cell Death Differ. 2022 May;29(5):988-1003. (PMID: 35034103)
Nat Commun. 2021 Sep 1;12(1):5214. (PMID: 34471131)
Cancer Cell Int. 2019 May 09;19:125. (PMID: 31168298)
Nucleic Acids Res. 2015 Dec 2;43(21):10474-91. (PMID: 26405199)
Cell. 1999 Feb 5;96(3):375-87. (PMID: 10025403)
Mol Cell. 2021 Feb 18;81(4):801-810.e3. (PMID: 33385326)
PLoS One. 2014 Jun 13;9(6):e98561. (PMID: 24926850)
Oncotarget. 2017 Jul 4;8(27):43953-43966. (PMID: 28410200)
Annu Rev Immunol. 1997;15:177-202. (PMID: 9143686)
PLoS One. 2010 Jul 01;5(7):e11397. (PMID: 20617180)
Cell Death Differ. 2016 Feb;23(2):347-57. (PMID: 26206090)
Biol Chem. 2018 Oct 25;399(11):1265-1276. (PMID: 29908124)
Nat Commun. 2020 Dec 3;11(1):6182. (PMID: 33273464)
Molecules. 2017 Nov 23;22(12):. (PMID: 29168755)
Mol Cancer. 2014 Sep 14;13:216. (PMID: 25217841)
Tumour Biol. 2016 Oct 21;:. (PMID: 27770311)
Biochem Pharmacol. 2021 Mar;185:114407. (PMID: 33421376)
Nat Rev Cancer. 2007 Jul;7(7):495-507. (PMID: 17568790)
PLoS Pathog. 2019 Apr 24;15(4):e1007541. (PMID: 31017975)
Immunity. 2015 Feb 17;42(2):332-343. (PMID: 25692705)
mBio. 2019 Dec 3;10(6):. (PMID: 31796535)
PLoS One. 2015 Jun 10;10(6):e0129190. (PMID: 26061048)
Int J Mol Sci. 2021 Sep 22;22(19):. (PMID: 34638533)
Nat Struct Mol Biol. 2016 Jun;23(6):522-30. (PMID: 27111890)
Gastroenterology. 2018 Aug;155(2):542-556. (PMID: 29702115)
J Exp Clin Cancer Res. 2023 Sep 30;42(1):256. (PMID: 37775817)
Cell. 2000 Oct 27;103(3):457-66. (PMID: 11081632)
Annu Rev Biochem. 1995;64:897-934. (PMID: 7574504)
J Transl Med. 2022 Dec 24;20(1):618. (PMID: 36566215)
Nat Rev Mol Cell Biol. 2021 Apr;22(4):266-282. (PMID: 33495651)
Nature. 2017 Aug 24;548(7668):466-470. (PMID: 28759889)
Nat Rev Cancer. 2012 Jan 19;12(2):84-8. (PMID: 22257949)
Pediatr Cardiol. 2020 Feb;41(2):341-349. (PMID: 31953571)
Oncogene. 2020 Jan;39(1):1-16. (PMID: 31462710)
Mol Cell. 2019 Sep 19;75(6):1270-1285.e14. (PMID: 31351877)
Nature. 2009 Oct 22;461(7267):1071-8. (PMID: 19847258)
Nucleic Acids Res. 2015 Apr 20;43(7):3712-25. (PMID: 25779046)
J Biol Chem. 2015 May 1;290(18):11741-8. (PMID: 25792744)
Genes Dev. 2019 Jul 1;33(13-14):741-746. (PMID: 31171702)
Signal Transduct Target Ther. 2020 May 1;5(1):60. (PMID: 32355263)
Cell Death Differ. 2023 Feb;30(2):341-355. (PMID: 36376383)
Nature. 2008 Nov 27;456(7221):470-6. (PMID: 18978772)
Cell Discov. 2020 Apr 28;6:26. (PMID: 32351706)
Dig Liver Dis. 2017 May;49(5):545-551. (PMID: 28110922)
Genes Dev. 1996 Oct 1;10(19):2411-22. (PMID: 8843194)
Genes Dis. 2022 Dec 26;10(5):2064-2081. (PMID: 37492704)
Annu Rev Biochem. 2020 Jun 20;89:103-133. (PMID: 32176524)
Nat Rev Immunol. 2023 Feb;23(2):75-89. (PMID: 35831609)
EMBO J. 2011 Feb 2;30(3):524-32. (PMID: 21217645)
Cell Metab. 2023 Aug 8;35(8):1457-1473.e13. (PMID: 37329887)
Cell Cycle. 2008 Sep 15;7(18):2809-12. (PMID: 18769153)
Cell. 1996 Jul 12;86(1):159-71. (PMID: 8689683)
Cell. 1991 May 3;65(3):517-26. (PMID: 1826860)
J Clin Invest. 2012 Aug;122(8):2793-806. (PMID: 22751105)
N Engl J Med. 2009 Oct 8;361(15):1475-85. (PMID: 19812404)
Nat Rev Immunol. 2006 Apr;6(4):261-70. (PMID: 16498454)
Cell Rep. 2022 Mar 29;38(13):110421. (PMID: 35354054)
Mol Cell. 2008 Nov 21;32(4):519-28. (PMID: 19026782)
DNA Repair (Amst). 2019 Sep;81:102651. (PMID: 31302005)
Nat Genet. 2016 Oct;48(10):1185-92. (PMID: 27571260)
Cancer Biomark. 2022;34(4):545-553. (PMID: 35275519)
Cancers (Basel). 2021 Sep 30;13(19):. (PMID: 34638425)
Biology (Basel). 2018 Dec 20;8(1):. (PMID: 30577491)
Oncotarget. 2017 Mar 21;8(12):19980-19996. (PMID: 28212545)
Nat Rev Cancer. 2007 Nov;7(11):861-9. (PMID: 17943134)
Front Cell Dev Biol. 2023 Nov 14;11:1292925. (PMID: 38033868)
Invest Ophthalmol Vis Sci. 2022 Apr 1;63(4):17. (PMID: 35472218)
EMBO Rep. 2006 Mar;7(3):303-7. (PMID: 16440002)
Front Genet. 2019 Apr 26;10:364. (PMID: 31080456)
Autophagy. 2012 Aug;8(8):1185-96. (PMID: 22627293)
Annu Rev Biochem. 2015;84:291-323. (PMID: 25784052)
Nat Rev Cancer. 2020 Jun;20(6):303-322. (PMID: 32300195)
Nature. 2011 Jun 15;474(7351):395-8. (PMID: 21677757)
EMBO J. 2001 Aug 1;20(15):4214-21. (PMID: 11483524)
Gut. 2017 Jan;66(1):107-117. (PMID: 26475630)
Cell. 1997 May 30;89(5):799-809. (PMID: 9182768)
Antioxid Redox Signal. 2014 Jan 20;20(3):460-73. (PMID: 23725295)
Cell. 2013 Oct 24;155(3):688-98. (PMID: 24119841)
Nat Commun. 2019 Jul 30;10(1):3401. (PMID: 31363086)
Cell Death Discov. 2023 Jan 30;9(1):36. (PMID: 36717552)
MicroPubl Biol. 2023 Feb 2;2023:. (PMID: 36818311)
Neurogenetics. 2010 Feb;11(1):143-4. (PMID: 19653017)
Trends Cell Biol. 2022 Sep;32(9):733-745. (PMID: 35643889)
Antioxid Redox Signal. 2017 Oct 20;27(12):839-854. (PMID: 28657332)
Mol Cell. 2013 Feb 21;49(4):657-67. (PMID: 23273981)
BMC Genomics. 2008 Apr 10;9:157. (PMID: 18402656)
J Biol Chem. 2018 Aug 24;293(34):13284-13296. (PMID: 29980600)
MedComm (2020). 2023 Apr 17;4(3):e262. (PMID: 37077773)
Mol Cell. 2014 Feb 6;53(3):458-70. (PMID: 24462112)
Crit Rev Biochem Mol Biol. 2011 Aug;46(4):271-83. (PMID: 21524151)
Elife. 2022 May 16;11:. (PMID: 35575473)
Trends Cell Biol. 2019 Aug;29(8):647-659. (PMID: 31176528)
Cell. 2019 Mar 7;176(6):1447-1460.e14. (PMID: 30799039)
Oncogene. 2012 May 31;31(22):2794-804. (PMID: 21986946)
Biomed Pharmacother. 2023 May;161:114519. (PMID: 36906975)
Hum Mol Genet. 2009 Jun 15;18(12):2140-8. (PMID: 19304781)
Nucleic Acids Res. 2016 Jun 20;44(11):5068-82. (PMID: 27174936)
PLoS One. 2013;8(1):e55665. (PMID: 23383259)
Mol Cancer Res. 2011 Apr;9(4):476-84. (PMID: 21357441)
Cell Death Discov. 2021 Aug 11;7(1):210. (PMID: 34381023)
Clin Res Hepatol Gastroenterol. 2018 Feb;42(1):82-91. (PMID: 28578939)
Science. 2006 Jan 13;311(5758):230-2. (PMID: 16357227)
PLoS Genet. 2017 May 24;13(5):e1006804. (PMID: 28542199)
Mol Cell. 2006 Dec 28;24(6):841-51. (PMID: 17189187)
Biomolecules. 2020 May 18;10(5):. (PMID: 32443616)
Nature. 2001 May 17;411(6835):366-74. (PMID: 11357144)
Cardiovasc Res. 2019 Aug 1;115(10):1519-1532. (PMID: 30544252)
Cell Rep. 2015 Oct 13;13(2):251-9. (PMID: 26440899)
Nucleic Acids Res. 2012 Aug;40(14):6800-7. (PMID: 22495932)
EMBO J. 2002 Jun 3;21(11):2746-56. (PMID: 12032087)
Mol Biol Evol. 2008 Nov;25(11):2255-67. (PMID: 18687770)
Theranostics. 2020 Jul 23;10(20):9348-9363. (PMID: 32802196)
Mol Cell. 2023 Jan 5;83(1):139-155.e9. (PMID: 36521489)
Genes (Basel). 2023 Sep 19;14(9):. (PMID: 37761957)
Cell Death Differ. 2021 Aug;28(8):2450-2464. (PMID: 33742136)
Nature. 2020 Mar;579(7798):291-296. (PMID: 32103174)
Cancer Res. 2012 Aug 15;72(16):4225-37. (PMID: 22693249)
RNA. 2022 Dec;28(12):1582-1596. (PMID: 36127124)
Nat Commun. 2018 May 3;9(1):1783. (PMID: 29725044)
Nucleic Acids Res. 2017 Sep 6;45(15):8647-8660. (PMID: 28911119)
Math Biosci Eng. 2022 Jan 7;19(3):2424-2452. (PMID: 35240791)
Cancer Discov. 2023 Jul 7;13(7):1521-1545. (PMID: 37026695)
Nat Med. 2019 Dec;25(12):1873-1884. (PMID: 31806906)
Nat Commun. 2020 Feb 20;11(1):987. (PMID: 32080190)
Neurobiol Dis. 2021 Nov;159:105481. (PMID: 34411703)
Sci Transl Med. 2020 Feb 19;12(531):. (PMID: 32075942)
Mol Cell. 2018 Sep 6;71(5):745-760.e5. (PMID: 30193098)
Nature. 2015 Apr 2;520(7545):57-62. (PMID: 25799988)
Biomed Pharmacother. 2019 Oct;118:109266. (PMID: 31401397)
Cold Spring Harb Perspect Med. 2016 May 02;6(5):. (PMID: 27048304)
Sci Rep. 2017 Mar 02;7:43558. (PMID: 28252005)
Cell Death Differ. 2018 Mar;25(3):486-541. (PMID: 29362479)
EMBO Rep. 2023 Feb 6;24(2):e51800. (PMID: 36382803)
Front Immunol. 2023 Mar 15;14:1143980. (PMID: 37006268)
J Immunother Cancer. 2022 May;10(5):. (PMID: 35577506)
Br J Cancer. 2011 Aug 23;105(5):628-39. (PMID: 21772330)
Dose Response. 2020 Apr 23;18(2):1559325820917829. (PMID: 32704240)
Science. 1995 Feb 24;267(5201):1178-83. (PMID: 7855601)
Oncogene. 2009 Jan 15;28(2):195-208. (PMID: 18836484)
Nature. 2022 Mar;603(7899):145-151. (PMID: 35045565)
Wiley Interdiscip Rev RNA. 2023 Sep 18;:e1818. (PMID: 37722601)
Int J Biochem Cell Biol. 2018 Sep;102:138-150. (PMID: 30053504)
RNA. 2009 Jul;15(7):1233-40. (PMID: 19474147)
Nat Commun. 2022 Feb 23;13(1):1015. (PMID: 35197472)
Int J Mol Sci. 2022 Oct 18;23(20):. (PMID: 36293304)
Nat Rev Genet. 2016 Jan;17(1):19-32. (PMID: 26593421)
Clin Chim Acta. 2015 Jan 1;438:139-47. (PMID: 25172038)
Hum Mol Genet. 2022 Mar 31;31(7):1051-1066. (PMID: 34673944)
Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13084-9. (PMID: 8917548)
Cell. 2012 May 25;149(5):1060-72. (PMID: 22632970)
J Biol Chem. 2011 Feb 18;286(7):5414-22. (PMID: 21149450)
Trends Cell Biol. 2006 Jun;16(6):285-92. (PMID: 16682204)
Cancers (Basel). 2021 Dec 15;13(24):. (PMID: 34944924)
Am J Cancer Res. 2019 Aug 01;9(8):1504-1516. (PMID: 31497339)
Cell Res. 2022 Mar;32(3):254-268. (PMID: 34980897)
Nature. 2003 Jan 23;421(6921):436-40. (PMID: 12540918)
Elife. 2021 Jan 29;10:. (PMID: 33512317)
RNA. 2008 Dec;14(12):2671-84. (PMID: 18971324)
Vaccines (Basel). 2021 Sep 23;9(10):. (PMID: 34696164)
Nature. 2005 Jan 6;433(7021):77-83. (PMID: 15635413)
معلومات مُعتمدة: 32071240 National Natural Science Foundation of China; 82373526 National Natural Science Foundation of China
فهرسة مساهمة: Keywords: Cell cycle checkpoints; Cell death; DNA damage repair; DNA damage response (DDR); Oxidative stress; Small nucleolar RNAs (snoRNAs)
المشرفين على المادة: 0 (RNA, Small Nucleolar)
تواريخ الأحداث: Date Created: 20240808 Date Completed: 20240809 Latest Revision: 20240810
رمز التحديث: 20240812
مُعرف محوري في PubMed: PMC11308251
DOI: 10.1186/s40779-024-00553-4
PMID: 39118131
قاعدة البيانات: MEDLINE
الوصف
تدمد:2054-9369
DOI:10.1186/s40779-024-00553-4